期刊文献+

Myotonic Dystrophy Type I with Syringomyelia in a Young Patient

Myotonic Dystrophy Type I with Syringomyelia in a Young Patient
原文传递
导出
摘要 Myotonic dystrophy type 1 (DM1) is the most common disease causing muscle weakness and atrophy in adults. The prevalence of DM1 in China is not clear. DM1 is an autosomal dominant genetic disorder associated with the cytosine-thynline-guanine (CTG) repeat expansion in 3'untranslated region in dystrophia myotonica-protein kinase (DMPK) gene on chromosome 19q 13.3. In DM 1, CTG pathological repeat numbers are more than 50. The size of CTG repeat expansion is associated with the time of clinical phenotypes onset and severity The coexistence of DMI and syrlngomyelia is rare. Here, we report DM1 coexisting with syringonlyelia in a Chinese male patient. Myotonic dystrophy type 1 (DM1) is the most common disease causing muscle weakness and atrophy in adults. The prevalence of DM1 in China is not clear. DM1 is an autosomal dominant genetic disorder associated with the cytosine-thynline-guanine (CTG) repeat expansion in 3'untranslated region in dystrophia myotonica-protein kinase (DMPK) gene on chromosome 19q 13.3. In DM 1, CTG pathological repeat numbers are more than 50. The size of CTG repeat expansion is associated with the time of clinical phenotypes onset and severity The coexistence of DMI and syrlngomyelia is rare. Here, we report DM1 coexisting with syringonlyelia in a Chinese male patient.
出处 《Chinese Medical Journal》 SCIE CAS CSCD 2016年第4期487-489,共3页 中华医学杂志(英文版)
关键词 Myotonic Dystrophy Type 1 Peripheral Neuropathy: Syringomyelia Myotonic Dystrophy Type 1 Peripheral Neuropathy: Syringomyelia
  • 相关文献

参考文献10

  • 1Turner C, Hilton-Jones D, Lochmtlller H, Hanna MG. MRC centre for neuromuscular diseases 1st (1st December 2010), and 2nd (2nd May 2012) myotonic dystrophy workshops, London, UK and the myotonic dystrophy standards of care and national registry meeting, Newcastle, UK July 2011. Neuromuscul Disord 2013;23:1069-80. doi: 10.1016/j. nmd.2013.07.006.
  • 2Bouchard JP, Cossette L, Bassez G, Puymirat J. Natural history of skeletal muscle involvement in myotonic dystrophy type 1: A retrospective study in 204 cases. J Neurol 2015;262:285-93. doi: 10.1007/s00415-014-7570-x.
  • 3Orngreen MC, Arlien-Soborg P, Duno M, Hertz JM, Vissing J. Endocrine function in 97 patients with myotonie dystrophy type 1. J Neuro12012;259:912-20. doi: 10.1007/s00415-011-6277-5.
  • 4Dahlqvist JR, Orngreen MC, Witting N, Vissing J. Endocrine function over time in patients with myotonic dystrophy type 1. Eur J Neurol 2015;22:116-22. doi: 10.1111/ene.12542.
  • 5Li M, Wang Z J, Cui F, Yang F, Chen ZH, Ling L, et al. Electrophysiological features of patients with myotonic dystrophy type 1 (in Chinese). Natl Med J China 2013;93:345-7. doi: 10.3760/ cma.j .issn.0376-2491.2013.05.006.
  • 6Peric S, Stojanovic VR, Nikolic A, Kacar A, Basta I, Pavlovic S, et aL Peripheral neuropathy in patients with myotonic dystrophy type 1. Neurol Res 2013 ;35:331-5. doi: 10.1179/1743132812Y.0000000144.
  • 7Minnerop M, Weber B, Schoene-Bake JC, Roeske S, Mirbach S, Anspach C, et al. The brain in myotonic dystrophy 1 and 2: Evidence for a predominant white matter disease. Brain 2011;134(Pt 12):3530-46. doi: 10.1093/brain/awr299.
  • 8Levisky RB, Vianna-Morgante AM, Frota-Pessoa O, Scarf M, Tsanaclis AM, Levy JA. Myotonic dystrophy, syringomyelia, and 2/13 translocation in the same family. J Med Genet 1977;14:51-3.
  • 9Mascalchi M, Padovani R, Taiuti R, Quilici N. Syringomyelia in myotonic dystrophy due to spinal hemangioblastoma. Surg Neurol 1998;50:446-8. doi: 10.1016/S0090-3019(97)00050-5.
  • 10Gadalla SM, Lund M, Pfeiffer RM, Gortz S, Mueller CM, Moxley RT 3, et al. Cancer risk among patients with myotonic muscular dystrophy. JAMA 2011 ;306:2480-6. doi: 10.1001/jama.2011.1796.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部